PlainRecalls
FDA Drug Moderate Class II Terminated

Losartan Potassium/HCTZ, 100 mg/12.5 mg Tablet, 90-Count bottle, Manufactured by Torrent Pharmaceuticals, Distributed by RemedyRepack, Inc. Indiana, PA, 15701-3570, NDC 70518-1560-00.

Reported: May 8, 2019 Initiated: April 22, 2019 #D-1270-2019

Product Description

Losartan Potassium/HCTZ, 100 mg/12.5 mg Tablet, 90-Count bottle, Manufactured by Torrent Pharmaceuticals, Distributed by RemedyRepack, Inc. Indiana, PA, 15701-3570, NDC 70518-1560-00.

Reason for Recall

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 0.96 parts per million.

Details

Recalling Firm
RemedyRepack Inc.
Units Affected
44 HDPE bottles of 90 = 3,960 tablets
Distribution
Product was distributed to Florida.
Location
Indiana, PA

Frequently Asked Questions

What product was recalled?
Losartan Potassium/HCTZ, 100 mg/12.5 mg Tablet, 90-Count bottle, Manufactured by Torrent Pharmaceuticals, Distributed by RemedyRepack, Inc. Indiana, PA, 15701-3570, NDC 70518-1560-00.. Recalled by RemedyRepack Inc.. Units affected: 44 HDPE bottles of 90 = 3,960 tablets.
Why was this product recalled?
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 0.96 parts per million.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 8, 2019. Severity: Moderate. Recall number: D-1270-2019.